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Diabetes UK has recently listed a number of herbs and spices that have been clinically shown to improve blood glucose control in
type-2 diabetes patients and the diabetes high-risk group. With Aloe vera being top in this list, its health benefit along with health
and beauty/food retailers supplying it was illustrated in detail. Previous article from this laboratory scrutinised themerit of usingA.
vera as an alternative therapy to prescription antidiabetic drugs and the risk of using food supplements in the market which do not
qualify as drug preparations. In continuation of this discussion, the present study assesses three Aloe Pura brands and one Holland
and Barret brand of A. vera juice supplements in the UK market through chromatographic and spectroscopic analysis. While the
polysaccharide active ingredient, acemannan, appears to be within the recommended limit, it was found that Aloe Pura (one of
the best-selling brands for A. vera supplement) products have benzoate additive that does not appear in the supplement levels.
Moreover, two of the Aloe Pura brand juices contain methanol, suggesting that the International Aloe Science Council (IASC)
certification does not guarantee the medicinal quality of these products. The therapeutic fitness of such supplements is discussed.
1. Introduction
Throughout the history of mankind, nature has provided
unlimited access to potential medicines from the diverse
flora, fauna, and mineral resources [1]. Perhaps our ancestors
experimented by using the whole plant, whole roots, or
leaves and then moved on to their extracts, often by using
a blend of several plant parts or species, but the preferred
preparation of drugs of natural origin in the modern era is
based on purified single chemical entities [2]. Advances in
drug discovery through chemical synthesis and technologies
within the pharmaceutical/academic industries in the last few
decades have also shifted the balance of drug development
from natural to synthetic origin [3]. The large number of
our prescription drugs to date tracing their origin back to
natural resources [3–5], however, is a vivid reminder to the
prominent role still played by natural products in ourmodern
pharmacotherapies. Overall, while traditionalmedicine prac-
tices based on the whole plant or crude plant extracts remain
part of the healthcare system in many developing countries,
they are largely represented in Western countries to date by
exceptionally few examples of prescription drugs [e.g., [6]].
On the other hand, there are a plethora of evidences to show
the ever-increasing global impact of the food supplement
industry. Some market research estimates the global dietary
supplements business in 2016 as USD 132.8 billion, which is
further expected to reach USD 220.3 billion by 2022 [7]. As
dietary supplements are also often sold with various health
claims, rigorous quality assurance measures to guarantee the
products quality, safety, and efficacy must be employed to
ensure consumer health protection.
In the previous report from this laboratory [8], the merit
of using Aloe vera food supplements as antidiabetic drugs
was scrutinised following the listing of the plant along with
others by the Diabetes UK website [9] under the heading
of “Herbal and Natural Therapies” [10]. It was highlighted
that the recommendation by the Diabetes UK website for
people to get potential therapy from the healthcare outlets
like the “Holland and Barrett” could not be justified as there
has been no consensus among the scientific community on
using A. vera by its own as antidiabetic drug in the first
place [8]. It was also highlighted that the various health
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Figure 1: Aloe vera products available to the general public at the Holland and Barrett outlet.
supplements formulated for other diseases often with blends
of other plants could not be justified as modern therapy
for diabetes given the lack of scientific/clinical evidence for
such formulations [8]. In this communication, the checks
and balances of these formulations are further scrutinised
through the use of an electronic nose, analytical instruments.
For this purpose, four Aloe vera juices supplements were
selected from the Holland and Barrett outlet (Figure 1): three
of which were Aloe Pura brands bearing the International
Aloe Science Council (IASC) certificate stamp, while one
was that of Holland and Barrett’s own brand (Table 1).
In view of their composition, this article scrutinises the
existing quality control measure of A. vera food supplements
in their potential use as antidiabetic drug therapies. Data
from chromatographic and spectroscopy analysis showing
the inadequacy of the IASC certificate as a quality measure
is discussed.
2. Materials and Methods
2.1. Aloe vera Juice Samples. Four A. vera juice samples
were obtained from the shelves of Holland and Barret outlets
(Figure 1). Their batch number and content with respect
to A. vera and other ingredients mentioned therein as well
as preservatives and antioxidants listed are also detailed
(Table 1). The four samples were the subject of analysis and
scrutiny as detailed in the following sections.
2.2. HPLC Analysis. An Agilent 1200 series gradient HPLC
system composed of degasser (G1322A), quaternary pump
(G1322A), autosampler (G1329A), thermostat column com-
partment (G1316A) maintained at 25∘C, and a diode array
detector (G1315D) was used. Samples were diluted in the
buffer/solvent immediately before analysis and injected
(20𝜇L) onto a reverse phase column (Agilent, Eclipse Plus
C18, 5𝜇m, 4.9 × 150mm). The mobile phase composition for
routine analysis of components of diverse polarity range was
made by using a mixture of water (A) and methanol (B). The
composition of themobile phase at a flow rate of 1ml/minwas
rising from 10% to 90% B over a period of 50minutes. For the
preservatives analysis, an isocratic solvent system comprising
a mixture of 5mM ammonium acetic buffer of pH 4.4 and
methanol in the ratio 25 : 75 (v/v) was used. The detection of
the compounds was based on UV absorption as indicated in
Results and Discussion.
2.3. NMRAnalysis. Themeasurement ofA. vera components
by NMR has been carried out by following the American
Herbal Pharmacopoeia guidelines [11]. For this, the JEOL
500MHz instrument using D
2
O as a solvent containing 4,4-
dimethyl-4-silapentane-1-sulfonic acid (DSS) reference was
used.
2.4. Gas Chromatography Analysis. Following the detection
of methanol in some of the A. vera samples by NMR, accu-
rate quantification was done by using gas chromatography.
Samples were analysed using an Agilent Technologies 6850
Network GC system (DB5 capillary column, 30m, internal
diameter of 0.25mm, and 0.25 𝜇m film thickness), with a
split/splitless injection system used in the split mode (1 : 50).
Samples were delivered via the Agilent Technologies 7683B
series injector system at injection temperature of 150∘C,
injection volume of 1 𝜇l, and FID detection made at 250∘C.
The GC oven temperature was programmed at isothermal
condition at 30∘C. Helium was used as the carrier gas at
constant flow rate of 1ml/min.
3. Results and Discussion
Both the greenish leafy skin and inner white/colorless
parenchymatous tissue (source of Aloe gel) contain a long
list of bioactive compounds including amino acids, pep-
tides, and proteins/enzymes, carbohydrates (unique mono-,
di-, and polysaccharides), minerals and vitamins, and
secondary metabolites belonging to the general class of
anthraquinones/anthrones, chromones, phytosterols, and
phenolics. Several review articles describing the composition
and potential pharmacological/industrial application of A.
vera are available [e.g., [12–16]]. Individually, a range of
these compounds have shown some degree of antidiabetic
activity by their own but the polysaccharides of Aloe gel
have been mostly regarded as the main active component
for antidiabetic effects, while anthraquinones/anthrones are
attributed to the general purgative effect of Aloe [15, 16].
The bitter anthraquinones-dominated exudate obtained from
the outer skin of Aloe leaves (Aloe latex) is often used for
beverages flavouring while their laxative effects associated
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Table 1: Description of selected A. vera juices scrutinized in this analysis.
Aloe vera juice products Brand, code Description
Colon cleanse juice, cleansing and
purifying action Aloe Pura, AV-1
Batch number: 6194-1
(i) Whole leaf and unfiltered A. vera inner gel—100%
stabilised A. vera juice
(ii) Aloin removed
(iii) A. vera whole leaf and inner gel
(iv) Botanical blend (Glycyrrhiza glabra) [liquorice],
Taraxacum officinale [dandelion], L-glutamine, flaxseed
fibre [from Linum usitatissimum], apple pectin (from
Malus domestica) 0.3%, and fructooligosaccharides
Additives: antioxidant (ascorbic acid), preservatives
(potassium sorbate).
Directions: take 25ml once or twice daily
Digestive aid juice, soothing action Aloe Pura, AV-2
Batch number: 6290-1
(i) Whole leaf Aloe Vera and inner gel, unfiltered—100%
stabilised A. vera juice
(ii) Aloin removed
(iii) Botanical blend (Mentha piperita [peppermint],
Carica papaya [papaya], Chamomilla recutita
[chamomile], Foeniculum vulgare [fennel], bromelain
from Annas comosus).
Additives: antioxidant (ascorbic acid), preservatives
(potassium sorbate).
Directions: take 25ml once or twice daily
BIO-ACTIVE Aloe vera juice,
maximum strength Aloe Pura, AV-3
Batch number: 6349-1
(i) Whole leaf A. vera and inner gel, unfiltered—100%
stabilised A. vera juice
(ii) Aloin removed
(iii) Natural A. vera juice (99.99%)
Additives: antioxidant (ascorbic acid), preservatives
(potassium sorbate).
Directions: no dose recommendation
Maximum strength Aloe vera juice
supports healthy digestion Holland and Barrett, AV-4
Batch number: 6332-4
(i) A. vera leaf juice 99% with antioxidant (ascorbic acid)
and preservatives
(ii) A combination of filtered whole leaf and unfiltered
inner gel A. vera
(iii) Aloin removed
Additives: antioxidant (ascorbic acid), citric acid, and
preservatives (potassium sorbate, sodium benzoate).
Directions: take one tablespoon (15ml) one to three times
daily
with purgative activity are an interest in pharmaceutical
preparations [17, 18]. The most important purgative principle
of A. vera is aloin(a mixture of two isomers: aloin A (1) and
B (also named barbaloin, 2)), although a number of similar
compounds including dimeric forms and anthraquinones
(primarily aloe emodin, 6) are also known to occur in the
plant (Figure 2). The smooth muscle stimulant effect of
such compounds (primarily by the major component, aloin)
which is of interest in short-term weight loss formulations
and/or constipation therapy (like that by Senokot/Senna) is
a limitation in using A. vera for long-term therapy or as
food supplements. Accordingly, aloin is listed among the
substances which shall not be added to food (Regulation (EC)
number 1334/2008), while the 88/388/EEC of 22 June 1988
directive [19] limits the use of aloin as 0.1mg/kg in food and
as high as 50mg/kg in alcoholic beverages. Aloe vera juice
products certified by the IASC should also limit aloin (A and
B) in the finished products to 10 ppm or less. As the health
benefits of A. vera supplements are claimed to be realized
after long-term intake (about three months), methodologies
for industrial scale removal of anthraquinones/anthrones
(laxative components) are now routinely employed during
the manufacturing process. Accordingly, all the four A. vera
food supplement samples taken for the present analysis
display “aloin removed” marking in their labels (Table 1).
One of the most common methods of laxatives removal
is through nonspecific decolourisation (aloin and other
anthraquinones/anthrones (1–6) being orange/yellow in
colour) by activated carbon or charcoal [11]. Various other
methods of removal and A. vera preparations for food
and medicine are also reported [20, 21]. The method of
aloin removal from the Aloe juice food supplements in this
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Figure 2: Structures of some of the key pharmacologically active compounds of Aloe vera.
study (Table 1) is, however, not known. Analysis of these
samples by HPLC using UV detection at 250 nm confirmed
the removal of these phenolic compounds: in fact, the
two principal components of these products by the HPLC
methodology of analysis were ascorbic acid and potassium
sorbate/sodium benzoate which are the antioxidant and
preservative additives, respectively (Figure 3). Similar results
were obtained when the chromatogram was monitored at
280 and even 215 nm (data not shown) where the weakest
chromophores are usually picked up. It is worth noting that
the chromatographic system employed using a methanol
gradient from 10 to 90% was optimised to detect a range
of secondary metabolites from glycosides to nonpolar con-
stituents. Hence, despite the fact that phenolic compounds in
medicinal plants are known to be attributed to antioxidant
and antidiabetic mechanisms of action [22–30], the modern
A. vera medicine/food supplement preparations appear to
have lost these groups of natural products. For example,
anthraquinones of A. vera such as aloe emodin and their
glycosides have been shown to have antidiabetic effect both in
vitro and in vivo [31–35]. They (including aloin) also display
anti-inflammatory effects both in cellular and animal models
[36, 37]. Similarly, the therapeutic potentials of aloesin and
aloe chromones have been well recognised [38, 39]. All
these phenolic natural products are missing in Aloe food
supplements as they are effectively removed by the industrial
processing procedures employed. Other studies on A. vera
food supplements also reported that polyphenols including
flavonoids and tannins, which are effectively removed during
the industrial processing, cannot be detected [40].
Despite the fact that two of the Aloe Pura products
(AV-1 and AV-2) are labelled to contain a blend of for-
mulations with a range of other plant products (Table 1),
the HPLC profile (Figure 3) does not appear to show
phenolic compounds in any comparable concentrations to
the additives. As it is intriguing to find such high level of
antioxidant/preservatives as prominent peaks of the HPLC
analysis and the Aloe Pura products are being sold as 100%
natural juice, it was worthwhile to quantify this additive
by using authentic compounds as external standard. By
constructing a concentration-response curve for ascorbic
acid which gives straight line equations with 𝑟2 value of 0.999,
its concentration in the A. vera juices could be quantified. As
shown in Table 2, all of the products have around 1.5mg/ml of
ascorbic acid (∼0.15%of the products (w/v)) and, as explained
in the following text, this is equivalent to the active ingredient
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Figure 3: HPLC profile of Aloe vera juices. From lower to upper traces are AV-1, AV-2, AV-3, and AV-4, respectively. The chromatogram was
obtained from 5-fold dilution of the samples and UVmonitoring at 250 nm. Peaks at 2.1 and 23.2min represent the ascorbic acid antioxidant
and potassium sorbate/sodium benzoate preservative additives, respectively. The instrumental set-up was as described in Materials and
Methods and the mobile phase was a mixture of water and methanol.
that is claimed to be responsible for the potential antidiabetic
effect.
The chromatographic peak at 23.2min (Figure 3) which
corresponds to potassium sorbate is very intriguing. First,
AV-4 which is labelled to contain sodium benzoate preser-
vative in addition to potassium sorbate did not give addi-
tional peak, while quantitative measure using potassium
sorbate standard did not give the expected concentration-
dependent correlation graph with wider range of linearity.
It was thus suspected that potassium sorbate and sodium
benzoate are coeluted under the chromatographic system
leading to the appearance of the peak at 23.2min at even
much higher concentration than expected. Analysis of the
UV spectrum of this peak at 23.2min and spiking studies
confirmed the two compounds being coeluted together (data
not shown). Hence, a chromatographic method that allows
the resolution of the two preservative drugs was developed.
As shown in Figure 4(a), the use of ammonium acetate
buffer (0.39 g/L (5mM), pH = 4.4, by using glacial acetic
acid) and methanol in the ratio of 25 : 75 (v/v) as an iso-
cratic elution system resulted in the complete separation
of the two preservatives. On this basis, the detection and
quantification of these preservatives in all A. vera samples
were established. As shown in Figure 4(b), Aloe Pura prod-
ucts (AV-1, AV-2, and AV-3) which bear labels to contain
only potassium sorbate as preservative contain benzoate
additive in good amounts. Quantitative analysis of these
preservatives using this methodology is shown in Table 2.
As explained in the latter section, the presence of benzoate
in all of the samples analysed was further confirmed by
NMR.
Fresh A. vera gel is about 99% water and must contain
the polysaccharide active component, principally acemannan
(Figure 2). The presence of acetylated polysaccharides at or
above 5% dry weight in A. vera leaf juice and inner leaf
juice has been recommended by the IASC [11] but variability
from 1.2 to 10.2% has been reported in the various literature.
The best methodology for the detection and quantification
of Aloe polysaccharide is the 1H NMR spectroscopy and it
was employed herein to analyse the four juice products in
question following the standard procedure published by the
American Pharmacopoeia [11].
The 1H NMR profile of the three common additives of
A. vera products is shown in Figure 5. On this basis, the
three Aloe Pura products that are supposed to contain only
potassium sorbate as preservative clearly have benzoate as
evidenced from the characteristic peaks at 𝛿 7.87 (2H), 7.55
(1H), and 7.49 (2H) (Figure 6). Since these characteristic
peaks were evident in AV-3 which does not have the blended
formulation with other herbal products, while they promi-
nently occur in AV-4 which is stated in its label to have
this preservative, the detection of benzoate additive in Aloe
Pura products (in good agreement with the HPLC results)
could be confirmed by NMR. On the basis of the 1H NMR
integral analysis, the ratio of the sorbate to benzoate seems
to be ∼4 : 1 in Aloe Pura products, while estimation of their
concentration using the more accurate quantitative HPLC
method is presented in Table 2.Thus, the labelling of the three
Aloe Pura brand products along with the “100% stabilized
Aloe vera juice” claim needs a revision.
The acetylated polysaccharides markers at ∼𝛿 2.1 in the
1H NMR spectrum appear to have very small integral value
as compared to the additives and the calculated estimated
value using the established procedures [11, 41, 42] was less
than 0.2% (Table 2). Considering that Aloe vera juice is
∼99% water, there is no doubt that these products meet the
IASC requirement of ≥5% acetylated polysaccharides on dry
weight basis. It was noticed, however, that the acetylated
polysaccharide(s) 1H NMR signal appear to diminish over
time evenwhen the products were kept in the fridge following
the opening of the bottle (data not shown). The variability of
A. vera products in acemannan content depending on various
manufacturing conditions such as drying has also been
described in the various literature [e.g., [43]]. Hence, despite
the presence of the above-said stabilisers (antioxidant and
preservatives), the quality of A. vera juice can considerably
change over time (within a week) and the big bottle (0.5–1 L)
products for the stated small daily doses (Table 1) do not seem
to be a reasonable packaging methodology. Fresh A. vera gel
thatwe obtain fromhome-grownmaterial also appears to lose
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ammonium acetic buffer in isocratic condition. The top and lower panels
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0 5 10 15
(min)
20
AV-1
AV-2
AV-3
AV-4(m
AU
)
3500
3000
2500
2000
1500
1000
500
0
(b) HPLC profile of Aloe vera products showing additives. The chro-
matogram was obtained under an isocratic condition (see Figure 4(a)).
Ascorbic acid, sodium benzoate, and potassium sorbate are shown at
retention time of 2.0, 8.3, and 10.1min, respectively. For each sample, a pair
of spectra were obtained with UV detection at 225 (lower panel) and 250 nm
(upper panel)
Figure 4
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Figure 5: 1HNMRspectra of standard additives ofAloe vera.Theoverlapped spectra of ascorbic acid, potassium sorbate, and sodiumbenzoate
standards are shown. Calibration of the chemical shift was made by setting the DSS reference at zero ppm.
considerable amount of acetylated polysaccharide(s) when
the juice was treated with charcoal and filtration (data not
shown). Hence, keeping the active components of A. vera
juice intact is indeed a challenging task that could also be
attributed to the numerous variability of pharmacological
data reported from animal and clinical studies [8]. Variabil-
ity in the acylated polysaccharide content with respect to
biological activity has been reported. For example, complete
deacetylation not only alter the chemical/physical properties
of A. vera acemannan’s but also their biological effects
[44].
The 1H NMR has also been acclaimed for detecting
unwanted contaminants or adulterants in A. vera products
[11, 41]. Interestingly, two of the Aloe Pura products which
are blended with a number of other plant extracts in the
formulation (AV-1 and AV-2) appear to contain methanol as
evidenced from the characteristic peak at ∼𝛿 3.36 (Figures
6(a) and 6(b)). No food or medicinal product should contain
this toxic chemical and the detection of methanol as a
significant peak in the 1H NMR spectrum is worrying. By
employing a more accurate GC instrumentation, the concen-
tration ofmethanol in these products was quantified. For this,
a methanol reference extremal standard (Figure 7) was used
to plot a calibration graphwith 𝑟2 value of 0.999. Accordingly,
the presence of methanol in the two samples (AV-1 and AV-2)
which was detected by the 1HNMRwas quantified at ∼0.02%
(Table 2). Although this concentration of methanol for the
small volume of daily doses recommended by the product
manufacturers (Table 1) may not cause visible toxicity, the
presence of such toxic contaminant is highly undesirable.
The IASC certificate issued on the Aloe Pura prod-
ucts (except for the incomplete preservative labelling and
methanol contaminant) and quality assurance guarantee in
Holland and Barrett juices appear to be the beginning of
good standard practices within the industry. These checks
and balances, however, were far too inadequate as methanol
was already detected in the IASC certifiedAloe Pura products
which also contained the preservative benzoate that does not
8 Evidence-Based Complementary and Alternative Medicine
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(a) 1H NMR spectrum of AV-1. Notice the presence of benzoate (not listed
in the product label) andmethanol (toxic contaminant) characteristic peaks
in this preparation
Ascorbate
preservative
Malic acid
Acetylated
polysaccharides
Sorbate
preservative
Acetate
degradation product
Methanol
Sugar resonances
Malic
acid
(ppm)
8 7 6 5 4 3 2 1
Formic
acid
Benzoate
preservative
Sorbate
preservative
-Glucose
-Glucose (hidden)
＄2／
(b) 1HNMR spectrum of AV-2. Notice the presence of benzoate (not listed
in the product label) and methanol (toxic contaminant) characteristic peaks
in this preparation as shown in Figure 6(a)
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(c) 1H NMR spectrum of AV-3. Notice the presence of benzoate (not listed
in the product label) and absence of methanol from characteristic peaks
described in Figure 6(a)
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(d) 1HNMR spectrum of AV-4. Notice the prominent presence of benzoate
listed in the product label and absence of methanol from characteristic
peaks described in Figure 6(a)
Figure 6
appear in the labels. Some of the products (AV-1 and AV-
2) also claimed to have a blend of many botanical additives
(Table 1), although it is hard to detect (let alone quantify)
them by the 1H NMR and HPLC analysis employed herein.
While botanical blends are used for specific benefits of the
gastrointestinal system, their relevance to diabetes needs
other sets of scientific evidence.
In conclusion, medicinal plants with potential to treat
diseases including diabetes could be accepted as a therapeutic
option if the formulations are presented with proof of efficacy
and stringent measures to ascertain their quality and safety.
Aloe vera products containing the IASC or equivalent certifi-
cate of assurance could be a good starting point for standard-
ising the products and optimising them for research/clinical
trials on their antidiabetic potential. As a drug preparation,
however, the existing quality assurance system for these
food supplements does not appear to be sufficient even to
guarantee what the label says. In the absence of unequivocal
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Figure 7: Standard GC chromatograms of methanol. From top to bottom are 0.5, 0.25, 0.125, 0.0625, 0.03125, 0.015625, 0.007813, and
0.003906% methanol concentrations. The inset shows the calibration curve constructed from the data.
clinical evidence available for such formulations and quality
assurance measures that mirror pharmaceutical products,
these products cannot be recommended for treating diabetes.
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